Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Tumor Biology
Published in: Tumor Biology 5/2014

01-05-2014 | Research Article

Association of single nucleotide polymorphisms in ERCC2 gene and their haplotypes with esophageal squamous cell carcinoma

Authors: Yougai Zhang, Longzhi Wang, Peng Wang, Chunhua Song, Kaijuan Wang, Jianying Zhang, Liping Dai

Published in: Tumor Biology | Issue 5/2014

Login to get access

Abstract

Esophageal squamous cell carcinoma (ESCC), one of the leading causes of cancer death worldwide, occurs at a relatively high frequency in China. To investigate whether common excision repair cross-complementing rodent repair group 2 (ERCC2) variants (rs3916874 G>C, rs238415 C>G, rs1618536 G>A, rs1799793 G>A, and rsl3181 A>C) were associated with ESCC risk, a case–control study was conducted, including 405 cases with ESCC and 405 age and sex 1:1 matched cancer-free controls. The result showed that rsl3181 AC/CC genotypes was associated with an increased risk of ESCC (OR: 1.45, 95 % CI: 1.05–2.00), and two ERCC2 haplotypes Grs3916874Crs238415Grs1618536Grs1799793Crsl3181 (Hap5) and Grs3916874Grs238415Ars1618536Grs1799793Crsl3181 (Hap7) were associated with increased risk of ESCC (OR: 2.16, 95 % CI: 1.27–3.57 for Hap5 and OR: 3.72; 95 % CI: 1.89–6.63 for Hap7, respectively), while Grs3916874Grs238415Grs1618536Grs1799793Arsl3181 (Hap4) was associated with decreased risk of ESCC (OR: 0.47, 95 % CI: 0.35–0.71). Gene–environment interaction analysis by multifactor dimensionality reduction (MDR) software showed that there was an interaction among rs238415, rs1618536, and family history of cancer with a P value under 0.0001 (OR: 3.23: 95 % CI: 2.37–4.40). These results suggested that genetic variations in the ERCC2 gene were associated with risk of ESCC, and there was a significant interaction between gene polymorphisms and family history of cancer in the etiology of ESCC.
Literature
1.
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–917.CrossRefPubMed
2.
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. Cancer J Clin. 2011;61(2):69–92.CrossRef
3.
Gholipour C, Shalchi RA, Abbasi M. A histopathological study of esophageal cancer on the western side of the Caspian littoral from 1994 to 2003. Dis Esophagus. 2008;21(4):322–7.CrossRefPubMed
4.
Tran GD, Sun XD, Abnet CC, Fan JH, Dawsey SM, Dong ZW, et al. Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer. 2005;113(3):456–63.CrossRefPubMed
5.
Lin YS, Totsuka Y, He Y, Kikuchi S, Qiao YL, Ueda J, et al. Epidemiology of esophageal cancer in Japan and China. J Epidemiol. 2013;23(4):233–42.CrossRefPubMed
6.
Gao Y, Hu N, Han X, Giffen C, Ding T, Goldstein A, et al. Family history of cancer and risk for esophageal and gastric cancer in Shanxi, China. BMC Cancer. 2009;9(269).
7.
Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev. 2002;11(12):1513–30.PubMed
8.
Xing D, Qi J, Miao X, Lu W, Tan W, Lin D. Polymorphisms of DNA repair genes XRCC1 and XPD and their associations with risk of esophageal squamous cell carcinoma in a Chinese population. Int J Cancer. 2002;100(5):600–5.CrossRefPubMed
9.
Chu H, Gu D, Xu M, Xu Z, Gong Y, Gong W, et al. A genetic variant in ERCC2 is associated with gastric cancer prognosis in a Chinese population. Mutagenesis. 2013;28(4):441–6.CrossRefPubMed
10.
Ouyang FD, Yang FL, Chen HC, Khan MA, Huang FM, Wan XX, et al. Polymorphisms of DNA repair genes XPD, XRCC1, and OGG1, and lung adenocarcinoma susceptibility in Chinese population. Tumour Biol. 2013;34(5):2843–8. doi:10.​1007/​s13277-013-0844-6.CrossRefPubMed
11.
Dong Y, Zhuang L, Ma W. Comprehensive assessment of the association of ERCC2 Lys751Gln polymorphism with susceptibility to cutaneous melanoma. Tumour Biol. 2013;34(2):1155–60.CrossRefPubMed
12.
Gdowicz-Klosok A, Widel M, Rzeszowska-Wolny J. The influence of XPD, APE1, XRCC1, and NBS1 polymorphic variants on DNA repair in cells exposed to X-rays. Mutat Res. 2013;755(1):42–8.CrossRefPubMed
13.
Salnikova L, Chumachenko A, Belopolskaya O, Rubanovich A. Correlations between DNA polymorphism and frequencies of gamma-radiation induced and spontaneous cytogenetic damage. Health Phys. 2012;103(1):37–41.CrossRefPubMed
14.
Liu G, Zhou W, Yeap BY, Su L, Wain JC, Poneros JM, et al. XRCC1 and XPD polymorphisms and esophageal adenocarcinoma risk. Carcinogenesis. 2007;28(6):1254–8.CrossRefPubMed
15.
Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, et al. The structure of haplotype blocks in the human genome. Science. 2002;296(5576):2225–9.CrossRefPubMed
16.
Hahn LW, Ritchie MD, Moore JH. Multifactor dimensionality reduction software for detecting gene–gene and gene–environment interactions. Bioinformatics. 2003;19(3):373–82.CrossRef
17.
Ritchie MD, Dupont WD, Hahn LW, Parl FF. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet. 2001;69(1):138–47.CrossRefPubMedPubMedCentral
18.
Ritchie MD, Hahn LW, Moore JH. Power of multifactor dimensionality reduction for detecting gene–gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity. Genet Epidemiol. 2003;24(2):150–7.CrossRefPubMed
19.
Asaduzzaman Khan M, Tania M, Zhang DZ, Chen HC. Antioxidant enzymes and cancer. Chin J Cancer Res. 2010;22(2):87–92.CrossRef
20.
Ding DP, Ma WL, He XF, Zhang Y. XPD Lys751Gln polymorphism and esophageal cancer susceptibility: a meta-analysis of case–control studies. Mol Biol Rep. 2012;39(3):2533–40.CrossRefPubMed
21.
Duan XL, Gong H, Zeng XT, Ni XB, Yan Y, Chen W, et al. Association between XPD Asp312Asn polymorphism and esophageal cancer susceptibility: a meta-analysis. Asian Pac J Canc Prev. 2012;13(7):3299–303.CrossRef
22.
Zhang J, Qiu LX, Leaw SJ, Hu XC, Chang JH. The association between XPD Asp312Asn polymorphism and lung cancer risk: a meta-analysis including 16,949 subjects. Med Oncol. 2011;28(3):655–60.CrossRefPubMed
23.
Xue H, Lu Y, Lin B, Chen J, Tang F, Huang G. The effect of XPD/ERCC2 polymorphisms on gastric cancer risk among different ethnicities: a systematic review and meta-analysis. PLoS ONE. 2012;7(9):e43431.CrossRefPubMedPubMedCentral
24.
Chen B, Zhou Y, Yang P, Wu XT. ERCC2 Lys751Gln and Asp312Asn polymorphisms and gastric cancer risk: a meta-analysis. J Cancer Res Clin Oncol. 2011;137(6):939–46.CrossRefPubMed
25.
Zhu S, Zhang H, Tang Y, Wang J. Polymorphisms in XPD and hOGG1 and prostate cancer risk: a meta-analysis. Urol Int. 2012;89(2):233–40.CrossRefPubMed
26.
Wang M, Gu D, Zhang Z, Zhou J, Zhang Z. XPD polymorphisms, cigarette smoking, and bladder cancer risk: a meta-analysis. J Toxicol Environ Health. 2009;72(11–12):698–705.CrossRef
27.
Yuan H, Niu YM, Wang RX, Li HZ, Chen N. Association between XPD Lys751Gln polymorphism and risk of head and neck cancer: a meta-analysis. Genet Mol Res. 2011;10(4):3356–64.CrossRefPubMed
28.
Feng Z, Ni Y, Dong W, Shen H, Du J. Association of ERCC2/XPD polymorphisms and interaction with tobacco smoking in lung cancer susceptibility: a systemic review and meta-analysis. Mol Biol Rep. 2012;39(1):57–69.CrossRefPubMed
29.
Zhang Y, Ding D, Wang X, Zhu Z, Huang M, He X. Lack of association between XPD Lys751Gln and Asp312Asn polymorphisms and colorectal cancer risk: a meta-analysis of case–control studies. Int J Color Dis. 2011;26(10):1257–64.CrossRef
30.
Zhang RC, Mou SH. Polymorphisms of excision repair gene XPD Lys751Gln and hOGG1 Ser326Cys might not be associated with hepatocellular carcinoma risk: a meta-analysis. Tumour Biol. 2013;34(2):901–7.CrossRefPubMed
31.
Hu YY, Yuan H, Jiang GB, Chen N, Wen L, Leng WD, et al. Associations between XPD Asp312Asn polymorphism and risk of head and neck cancer: a meta-analysis based on 7,122 subjects. PLoS ONE. 2012;7(4):e35220.CrossRefPubMedPubMedCentral
32.
Yin JY, Vogel U, Ma Y, Qi R, Wan H. HapMap-based study of the DNA repair gene ERCC2 and lung cancer susceptibility in a Chinese population. Carcinogenesis. 2009;30(7):1181–5.CrossRefPubMed
33.
Matsa LS, Rangaraju A, Vengaldas V, Latifi M, Hossein M, Jahromil V, et al. Haplotypes of NOS3 gene polymorphisms in dilated cardiomyopathy. PLoS ONE. 2013;8(7):e70523.CrossRefPubMedPubMedCentral
34.
Fan Y, Yuan JM, Wang R, Gao YT, Yu MC. Alcohol, tobacco and diet in relation to esophageal cancer: the Shanghai cohort study. Nutr Cancer. 2008;60(3):354–63.
35.
Kamangar F, Chow WH, Abnet CC, Dawsey SM. Environmental causes of esophageal cancer. Gastroenterol Clin N Am. 2009;38(1):27–57.CrossRef
36.
Gao Y, Hu N, Han XY, Ding T, Giffen C, Goldstein AM, et al. Risk factors for esophageal and gastric cancers in Shanxi Province, China: a case–control study. Cancer Epidemiol. 2011;35(6):e91–9.
37.
He Z, Zhao Y, Guo C, Liu Y, Sun M, Liu F, et al. Prevalence and risk factors for esophageal squamous cell cancer and precursor lesions in Anyang, China: a population-based endoscopic survey. Br J Cancer. 2010;103(7):1085–8.CrossRefPubMedPubMedCentral
38.
Coffey CS, Hebert PR, Ritchie MD, Krumholz HM, Gaziano JM, Ridker PM. An application of conditional logistic regression and multifactor dimensionality reduction for detecting gene–gene interactions on risk of myocardial infarction the importance of model validation. BMC Bioinforma. 2004;5(49):10.
Metadata
Title
Association of single nucleotide polymorphisms in ERCC2 gene and their haplotypes with esophageal squamous cell carcinoma
Authors
Yougai Zhang
Longzhi Wang
Peng Wang
Chunhua Song
Kaijuan Wang
Jianying Zhang
Liping Dai
Publication date
01-05-2014
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 5/2014
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-013-1553-x

Other articles of this Issue 5/2014

Tumor Biology 5/2014 Go to the issue

Research Article

The CYP1B1 Leu432Val polymorphism and risk of urinary system cancers

Research Article

Possible relations between oxidative damage and apoptosis in benign prostate hyperplasia and prostate cancer patients

Research Article

HMGCR is necessary for the tumorigenecity of esophageal squamous cell carcinoma and is regulated by Myc

Research Article

PTPN6 expression is epigenetically regulated and influences survival and response to chemotherapy in high-grade gliomas

Research Article

Expression of CXCL10 is associated with response to radiotherapy and overall survival in squamous cell carcinoma of the tongue

Research Article

Microsatellite instability and promoter hypermethylation in colorectal cancer in India
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits